Equillium (EQ) Institutional Ownership $0.72 +0.02 (+2.86%) (As of 11/20/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Equillium (NASDAQ:EQ)CurrentInstitutional OwnershipPercentage27.05%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$3.53MNumber ofInstitutional Sellers(last 12 months)0 Get EQ Insider Trade Alerts Want to know when executives and insiders are buying or selling Equillium stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data EQ Institutional Buying and Selling by Quarter Ad Porter & CompanyWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. Equillium Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/9/2024 Renaissance Technologies LLC300,400$208K0.0%+43.6%0.852% 5/10/2024 Acadian Asset Management LLC108,691$249K0.0%N/A0.308% 2/12/2024 Decheng Capital LLC4,447,308$3.22M0.9%N/A12.663% 8/9/2023 DCF Advisers LLC111,623$84K0.0%-28.9%0.324% 5/2/2023 Victory Capital Management Inc.345,861$252K0.0%-89.2%1.005% 2/14/2023 True North Advisors LLC265,370$265K0.1%+50.5%0.771% Get the Latest News and Ratings for EQ and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Equillium and its competitors with MarketBeat's FREE daily newsletter. 2/13/2023 Callan Capital LLC103,688$110K0.0%N/A0.301% 2/9/2023 Victory Capital Management Inc.3,198,745$3.52M0.0%-12.4%9.296% 1/24/2023 Capital CS Group LLC24,000$25K0.0%N/A0.070% 11/7/2022Virtu Financial LLC24,141$54K0.0%N/A0.070% 11/2/2022 Victory Capital Management Inc.3,651,084$8.11M0.0%+2.1%10.651% 8/11/2022 DCF Advisers LLC114,027$233K0.1%-31.2%0.333% 8/1/2022 Victory Capital Management Inc.3,577,211$7.30M0.0%-0.6%10.436% 5/16/2022 Cota Capital Management LLC562,278$1.77M0.4%N/A1.640% 5/10/2022Decheng Capital Management III Cayman LLC4,447,308$14.01M4.3%N/A12.975% 5/4/2022 Victory Capital Management Inc.3,597,799$11.33M0.0%+8.2%10.495% 2/15/2022 Samsara BioCapital LLC615,541$2.32M0.5%-16.6%2.094% 2/7/2022 Victory Capital Management Inc.3,325,050$12.47M0.0%+4.9%11.313% 11/16/2021 Two Sigma Securities LLC83,948$573K0.0%N/A0.286% 11/12/2021 Geode Capital Management LLC154,185$1.05M0.0%+2.4%0.525% 11/2/2021 Victory Capital Management Inc.3,170,199$21.62M0.0%+9.4%10.789% 8/17/2021 Samsara BioCapital LLC738,176$4.35M0.5%-3.4%2.512% 8/17/2021 Bridgeway Capital Management LLC141,200$832K0.0%+38.4%0.481% 8/16/2021 State Street Corp30,756$181K0.0%N/A0.105% 8/16/2021 Goldman Sachs Group Inc.218,162$1.29M0.0%N/A0.742% 8/13/2021 DCF Advisers LLC77,538$457K0.2%N/A0.267% 8/13/2021 Geode Capital Management LLC150,582$886K0.0%+16.7%0.519% 8/13/2021 Vanguard Group Inc.840,545$4.95M0.0%+31.4%2.894% 8/11/2021 Deutsche Bank AG356,461$2.10M0.0%+1.8%1.227% 8/3/2021 Victory Capital Management Inc.2,896,875$17.06M0.0%+1.0%9.975% 5/21/2021 Citadel Advisors LLC21,366$153K0.0%N/A0.074% 5/18/2021 Millennium Management LLC63,012$451K0.0%+413.3%0.217% 5/18/2021 Citadel Advisors LLC21,366$153K0.0%N/A0.074% 5/18/2021 Samsara BioCapital LLC764,403$5.47M1.0%-28.8%2.632% 5/17/2021 Sphera Funds Management LTD.254,184$1.82M0.1%N/A0.875% 5/12/2021 Northern Trust Corp34,055$243K0.0%+42.9%0.117% 5/12/2021 Geode Capital Management LLC129,072$922K0.0%+99.0%0.444% 5/7/2021BlackRock Inc.32,423$232K0.0%-53.1%0.112% 5/4/2021 Victory Capital Management Inc.2,868,858$20.51M0.0%+28.1%9.879% 4/29/2021 Vigilare Wealth Management18,000$129K0.1%-32.3%0.062% Financial Prophecy (Ad)The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.Including the name of the #1 company to buy.2/25/2021 Hsbc Holdings PLC16,944$94K0.0%N/A0.068% 2/24/2021Virtu Financial LLC18,247$98K0.0%N/A0.074% 2/17/2021 Jane Street Group LLC21,230$114K0.0%N/A0.086% 2/16/2021 Squarepoint Ops LLC20,235$108K0.0%N/A0.082% 2/11/2021 Northern Trust Corp23,827$127K0.0%+82.2%0.096% 2/10/2021 Renaissance Technologies LLC41,509$222K0.0%-61.3%0.168% 2/9/2021 Bank of New York Mellon Corp15,261$82K0.0%N/A0.062% 2/5/2021BlackRock Inc.69,153$370K0.0%+221.1%0.280% 2/1/2021 Victory Capital Management Inc.2,239,735$11.98M0.0%-4.9%9.057% 1/14/2021 Vigilare Wealth Management26,600$142K0.1%N/A0.108% 11/16/2020 Samsara BioCapital LLC1,074,285$6.20M1.7%N/A4.344% 11/13/2020 Morgan Stanley9,573$55K0.0%N/A0.039% 11/13/2020Cetera Advisor Networks LLC57,425$331K0.0%N/A0.298% 11/9/2020 Victory Capital Management Inc.2,354,309$13.59M0.0%+36.2%12.222% 11/6/2020BlackRock Inc.21,535$125K0.0%+14.2%0.112% 11/5/2020 California Public Employees Retirement System12,100$70K0.0%N/A0.063% 11/5/2020 First Trust Advisors LP32,518$188K0.0%N/A0.169% (Data available from 1/1/2016 forward) EQ Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of EQ shares? During the previous two years, the following institutional investors and hedge funds held shares of Equillium shares: Decheng Capital LLC ($3.22M), True North Advisors LLC ($265K), Victory Capital Management Inc. ($252K), Acadian Asset Management LLC ($249K), Renaissance Technologies LLC ($208K), Callan Capital LLC ($110K), and DCF Advisers LLC ($84K).Learn more on EQ's institutional investors. What percentage of Equillium stock is owned by institutional investors? 27.05% of Equillium stock is owned by institutional investors. Learn more on EQ's institutional investor holdings. Which institutional investors have been buying Equillium stock? The following institutional investors have purchased Equillium stock in the last 24 months: Decheng Capital LLC ($4.45M), Acadian Asset Management LLC ($108.69K), Callan Capital LLC ($103.69K), Renaissance Technologies LLC ($91.20K), True North Advisors LLC ($89.06K), and Capital CS Group LLC ($24K). How much institutional buying is happening at Equillium? Institutional investors have bought a total of 4,863,947 shares in the last 24 months. This purchase volume represents approximately $3.76M in transactions. Which Equillium major shareholders have been selling company stock? The following institutional investors have sold Equillium stock in the last 24 months: Victory Capital Management Inc. ($3.31M), and DCF Advisers LLC ($45.40K). How much institutional selling is happening at Equillium? Institutional investors have sold a total of 3,350,623 shares in the last 24 months. This volume of shares sold represents approximately $2.60M in transactions. Related Companies Kezar Life Sciences Institutional Ownership INmune Bio Institutional Ownership Coya Therapeutics Institutional Ownership Nuvectis Pharma Institutional Ownership Milestone Pharmaceuticals Institutional Ownership Eupraxia Pharmaceuticals Institutional Ownership Anixa Biosciences Institutional Ownership Karyopharm Therapeutics Institutional Ownership Eliem Therapeutics Institutional Ownership Coherus BioSciences Institutional Ownership This page (NASDAQ:EQ) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Equillium, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Equillium With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
